Bacterial lysates in the prevention of asthma exacerbations in uncontrolled asthma: the Breathe study

G. de Boer (Rotterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), R. Hendriks (Rotterdam, Netherlands), G. Tramper (Rotterdam, Netherlands)

Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Session: Understanding the immunopathology that underlies airway obstructive diseases
Session type: Poster Discussion
Number: 5008
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. de Boer (Rotterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), R. Hendriks (Rotterdam, Netherlands), G. Tramper (Rotterdam, Netherlands). Bacterial lysates in the prevention of asthma exacerbations in uncontrolled asthma: the Breathe study. 5008

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis
Source: Eur Respir Rev, 29 (158) 190175; 10.1183/16000617.0175-2019
Year: 2020



Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Bacterial burden in rhinovirus-induced asthma exacerbations
Source: Lung Science Conference 2015
Year: 2015




Emergency visits for asthma: asthma exacerbations or poor asthma control?
Source: Eur Respir J 2004; 24: Suppl. 48, 598s
Year: 2004

Asthma control and exacerbation rate with omalizumab in Italian patients with severe allergic asthma: PROXIMA study
Source: International Congress 2017 – Asthma management
Year: 2017


Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



LSC Abstract – Bacterial burden in rhinovirus-induced asthma exacerbations
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015


Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009


Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 154s
Year: 2006

Montelukast reduces viral-induced asthma exacerbations: the PREVIA study
Source: Eur Respir J 2004; 24: Suppl. 48, 212s
Year: 2004

The prevention of virus-induced exacerbation of bronchial asthma in children
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012



Viral and bacterial infections in exacerbations of asthma and COPD
Source: Annual Congress 2004 - PG9 - The role of infection in airway inflammation and exacerbation
Year: 2004


COPD exacerbations: impact and prevention
Source: Breathe 2013; 9: 434-440
Year: 2013

Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
Source: Eur Respir J, 50 (6) 1701366; 10.1183/13993003.01366-2017
Year: 2017



Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Allergic asthma: determinants of asthma control
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008

Prevention and management of exacerbations of asthma and COPD
Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care
Year: 2010

Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019